ARAF and colorectal carcinoma: Therefore, in addition to direct genotoxicity, disruption of the epithelial barrier, and dysregulation of immune responses, ETBF has the potential to drive CRC by establishing a niche for other oncomicrobes, including pks+E. coli, to promote a pro-tumorigenic environment.